SCHEMBL14989883

SCHEMBL14989883

OC(c1ccc(F)cc1Cl)c1c(Cl)nc(Cl)n1-c1ccc(F)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 3/20 0.34
NR3C2 P08235 1/20 0.32
F2RL1 P55085 7/20 0.30
AOC3 Q16853 1/20 0.30
P2RX7 Q99572 1/20 0.30
GPBAR1 Q8TDU6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899572 0.92 GRM5 (0.33) MDM2NR3C2P2RX7
SCHEMBL900097 0.90 MDM2 (0.30) MDM2NR3C2
SCHEMBL899939 0.87 TRPC5 (0.34) MDM2NR3C2
SCHEMBL899125 0.87 NR3C2 (0.33) MDM2NR3C2AOC3P2RX7
SCHEMBL899670 0.84 NR3C2 (0.36) MDM2NR3C2
SCHEMBL898785 0.84 NR3C2 (0.33) MDM2NR3C2
SCHEMBL899633 0.82 NR3C2 (0.35) MDM2NR3C2
SCHEMBL898787 0.80 TRPC5 (0.33) MDM2NR3C2
SCHEMBL898060 0.80 TRPC5 (0.33) MDM2NR3C2
SCHEMBL899221 0.80 GLA (0.36) NR3C2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143929-A1 FUNGICIDAL IMIDAZOLES EI DU PONT DE NEMOURS AND COMPANY (US) 2013-06-06 US claimed
US-20130143929-A1 FUNGICIDAL IMIDAZOLES EI DU PONT DE NEMOURS AND COMPANY (US) 2013-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130143929-A1 FUNGICIDAL IMIDAZOLES CYP1A1, CYP1B1, CYP2E1 MDM2 1415/4885NR3C2 2193/4885F2RL1 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.